These findings pointed to a functional role for PKR in these malignancies and were further supported by analyses of PKR protein levels in AML patient samples which revealed that high PKR expression correlated with reduced overall survival and shorter disease remissions [24]. The gene discussed is EIF2AK2; the disease is acute myeloid leukemia.